Skip to content
Winfred
Sign up
Back to Startups
D

Dxcover

Follow

Dxcover develops multiomic spectral analysis technology for early cancer detection.

Glasgow, UK— Founded 2019— Website
£14.7MTotal raised

Dxcover is a clinical stage diagnostics company developing multiomic spectral analysis technology for the early detection of solid tumor cancers.

Filed accounts

Cash at bank

Members only

Net current assets

Members only

Total assets less current liabilities

Members only

Net assets

Members only

Shareholders' funds

Members only

Fixed assets

Members only

Cash, assets and headcount from Dxcover's latest Companies House filing — with year-on-year movement, free with a Winfred account.

Create free accountSign in

Categories

AI/MLHealthTechMedTech

Founders

MB

Matthew Baker

Co-Founder, CEO and President

DP

David Palmer

Chief Scientific Officer

Holly Butler

Holly Butler

Chief Technical Officer

Holly brings technical leadership and diagnostics experience as co-founder and chief technical officer at Dxcover. She previously led product development at the company following research roles at the University of Strathclyde and Lancaster University.

LinkedIn

Investors

  1. Series A
    £5.0M
    Eos Advisory
    Eos Advisory    LeadFollow-on
    SIS Ventures
    SIS Ventures    Follow-on
    University of Strathclyde
    University of Strathclyde    Follow-on
    NC
    Norcliffe Capital    Follow-on
    Maven
    Maven
    MC
    Macmillan Cancer Support
  2. Series A
    £9.7M
    Eos Advisory
    Eos Advisory    Lead
    Mercia Asset Management
    Mercia Asset Management    Lead
    Scottish Enterprise
    Scottish Enterprise    Lead
    University of Strathclyde
    University of Strathclyde    Lead
    SIS Ventures
    SIS Ventures    Lead
    NC
    Norcliffe Capital    Lead
    TB
    Thairm Bio    Lead
    EI
    European Innovation Council

Funding history